Literature DB >> 32004441

THEMIS-SHP1 Recruitment by 4-1BB Tunes LCK-Mediated Priming of Chimeric Antigen Receptor-Redirected T Cells.

Chuang Sun1, Peishun Shou2, Hongwei Du1, Koichi Hirabayashi1, Yuhui Chen1, Laura E Herring3, Sarah Ahn2, Yang Xu1, Kyogo Suzuki1, Guangming Li1, Ourania Tsahouridis1, Lishan Su2, Barbara Savoldo4, Gianpietro Dotti5.   

Abstract

Chimeric antigen receptor (CAR) T cell costimulation mediated by CD28 and 4-1BB is essential for CAR-T cell-induced tumor regression. However, CD28 and 4-1BB differentially modulate kinetics, metabolism and persistence of CAR-T cells, and the mechanisms governing these differences are not fully understood. We found that LCK recruited into the synapse of CD28-encoding CAR by co-receptors causes antigen-independent CAR-CD3ζ phosphorylation and increased antigen-dependent T cell activation. In contrast, the synapse formed by 4-1BB-encoding CAR recruits the THEMIS-SHP1 phosphatase complex that attenuates CAR-CD3ζ phosphorylation. We further demonstrated that the CAR synapse can be engineered to recruit either LCK to enhance the kinetics of tumor killing of 4-1BB CAR-T cells or SHP1 to tune down cytokine release of CD28 CAR-T cells.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  4-1BB; CAR-CD3ζ; CAR-Ts; CD28; chimeric antigen receptor; cytokine release syndrome (CRS); druggable engineering; kinase; phosphatase; phosphorylation; synapse

Mesh:

Substances:

Year:  2020        PMID: 32004441      PMCID: PMC7397569          DOI: 10.1016/j.ccell.2019.12.014

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  43 in total

1.  Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells.

Authors:  Omkar U Kawalekar; Roddy S O'Connor; Joseph A Fraietta; Lili Guo; Shannon E McGettigan; Avery D Posey; Prachi R Patel; Sonia Guedan; John Scholler; Brian Keith; Nathaniel W Snyder; Nathaniel Snyder; Ian A Blair; Ian Blair; Michael C Milone; Carl H June
Journal:  Immunity       Date:  2016-02-16       Impact factor: 31.745

2.  Phosphoproteomic analysis of chimeric antigen receptor signaling reveals kinetic and quantitative differences that affect cell function.

Authors:  Alexander I Salter; Richard G Ivey; Jacob J Kennedy; Valentin Voillet; Anusha Rajan; Eva J Alderman; Uliana J Voytovich; Chenwei Lin; Daniel Sommermeyer; Lingfeng Liu; Jeffrey R Whiteaker; Raphael Gottardo; Amanda G Paulovich; Stanley R Riddell
Journal:  Sci Signal       Date:  2018-08-21       Impact factor: 8.192

3.  Regulated Expansion and Survival of Chimeric Antigen Receptor-Modified T Cells Using Small Molecule-Dependent Inducible MyD88/CD40.

Authors:  Aaron E Foster; Aruna Mahendravada; Nicholas P Shinners; Wei-Chun Chang; Jeannette Crisostomo; An Lu; Mariam Khalil; Eva Morschl; Joanne L Shaw; Sunandan Saha; MyLinh T Duong; Matthew R Collinson-Pautz; David L Torres; Tania Rodriguez; Tsvetelina Pentcheva-Hoang; J Henri Bayle; Kevin M Slawin; David M Spencer
Journal:  Mol Ther       Date:  2017-07-08       Impact factor: 11.454

Review 4.  Myristylation and palmitylation of Src family members: the fats of the matter.

Authors:  M D Resh
Journal:  Cell       Date:  1994-02-11       Impact factor: 41.582

5.  Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells.

Authors:  Margherita Norelli; Barbara Camisa; Giulia Barbiera; Laura Falcone; Ayurzana Purevdorj; Marco Genua; Francesca Sanvito; Maurilio Ponzoni; Claudio Doglioni; Patrizia Cristofori; Catia Traversari; Claudio Bordignon; Fabio Ciceri; Renato Ostuni; Chiara Bonini; Monica Casucci; Attilio Bondanza
Journal:  Nat Med       Date:  2018-05-28       Impact factor: 53.440

6.  Eradication of Neuroblastoma by T Cells Redirected with an Optimized GD2-Specific Chimeric Antigen Receptor and Interleukin-15.

Authors:  Yuhui Chen; Chuang Sun; Elisa Landoni; Leonid Metelitsa; Gianpietro Dotti; Barbara Savoldo
Journal:  Clin Cancer Res       Date:  2019-01-07       Impact factor: 12.531

7.  T lymphocytes redirected against the kappa light chain of human immunoglobulin efficiently kill mature B lymphocyte-derived malignant cells.

Authors:  Juan Vera; Barbara Savoldo; Stephane Vigouroux; Ettore Biagi; Martin Pule; Claudia Rossig; Jessie Wu; Helen E Heslop; Cliona M Rooney; Malcolm K Brenner; Gianpietro Dotti
Journal:  Blood       Date:  2006-08-22       Impact factor: 22.113

8.  Dimerizer-mediated regulation of gene expression in vivo.

Authors:  Victor M Rivera; Lori Berk; Tim Clackson
Journal:  Cold Spring Harb Protoc       Date:  2012-07-01

9.  Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma/leukemia effects and safety.

Authors:  V Hoyos; B Savoldo; C Quintarelli; A Mahendravada; M Zhang; J Vera; H E Heslop; C M Rooney; M K Brenner; G Dotti
Journal:  Leukemia       Date:  2010-04-29       Impact factor: 11.528

10.  Remote control of therapeutic T cells through a small molecule-gated chimeric receptor.

Authors:  Chia-Yung Wu; Kole T Roybal; Elias M Puchner; James Onuffer; Wendell A Lim
Journal:  Science       Date:  2015-09-24       Impact factor: 47.728

View more
  41 in total

1.  Designed protein logic to target cells with precise combinations of surface antigens.

Authors:  Marc J Lajoie; Scott E Boyken; Alexander I Salter; Jilliane Bruffey; Anusha Rajan; Robert A Langan; Audrey Olshefsky; Vishaka Muhunthan; Matthew J Bick; Mesfin Gewe; Alfredo Quijano-Rubio; JayLee Johnson; Garreck Lenz; Alisha Nguyen; Suzie Pun; Colin E Correnti; Stanley R Riddell; David Baker
Journal:  Science       Date:  2020-08-20       Impact factor: 47.728

Review 2.  Signaling from T cell receptors (TCRs) and chimeric antigen receptors (CARs) on T cells.

Authors:  Ling Wu; Qianru Wei; Joanna Brzostek; Nicholas R J Gascoigne
Journal:  Cell Mol Immunol       Date:  2020-05-25       Impact factor: 11.530

3.  The role of SPAG1 in the assembly of axonemal dyneins in human airway epithelia.

Authors:  Amanda J Smith; Ximena M Bustamante-Marin; Weining Yin; Patrick R Sears; Laura E Herring; Nedyalka N Dicheva; Francesc López-Giráldez; Shrikant Mane; Robert Tarran; Margaret W Leigh; Michael R Knowles; Maimoona A Zariwala; Lawrence E Ostrowski
Journal:  J Cell Sci       Date:  2022-03-31       Impact factor: 5.285

4.  Dual Targeting CAR-T Cells with Optimal Costimulation and Metabolic Fitness enhance Antitumor Activity and Prevent Escape in Solid Tumors.

Authors:  Koichi Hirabayashi; Hongwei Du; Yang Xu; Peishun Shou; Xin Zhou; Giovanni Fucá; Elisa Landoni; Chuang Sun; Yuhui Chen; Barbara Savoldo; Gianpietro Dotti
Journal:  Nat Cancer       Date:  2021-09-23

Review 5.  Cellular kinetics: A clinical and computational review of CAR-T cell pharmacology.

Authors:  Timothy Qi; Kyle McGrath; Raghuveer Ranganathan; Gianpietro Dotti; Yanguang Cao
Journal:  Adv Drug Deliv Rev       Date:  2022-07-06       Impact factor: 17.873

6.  Noncanonical binding of Lck to CD3ε promotes TCR signaling and CAR function.

Authors:  Frederike A Hartl; Esmeralda Beck-Garcìa; Nadine M Woessner; Lea J Flachsmann; Rubí M-H Velasco Cárdenas; Simon M Brandl; Sanaz Taromi; Gina J Fiala; Anna Morath; Pankaj Mishra; O Sascha Yousefi; Julia Zimmermann; Nico Hoefflin; Maja Köhn; Birgitta M Wöhrl; Robert Zeiser; Kristian Schweimer; Stefan Günther; Wolfgang W Schamel; Susana Minguet
Journal:  Nat Immunol       Date:  2020-07-20       Impact factor: 25.606

7.  CAR T cells Targeting Human Immunoglobulin Light Chains Eradicate Mature B-cell Malignancies While Sparing a Subset of Normal B Cells.

Authors:  Raghuveer Ranganathan; Peishun Shou; Sarah Ahn; Chuang Sun; John West; Barbara Savoldo; Gianpietro Dotti
Journal:  Clin Cancer Res       Date:  2021-04-15       Impact factor: 12.531

8.  Comparative analysis of TCR and CAR signaling informs CAR designs with superior antigen sensitivity and in vivo function.

Authors:  Alexander I Salter; Anusha Rajan; Jacob J Kennedy; Richard G Ivey; Sarah A Shelby; Isabel Leung; Megan L Templeton; Vishaka Muhunthan; Valentin Voillet; Daniel Sommermeyer; Jeffrey R Whiteaker; Raphael Gottardo; Sarah L Veatch; Amanda G Paulovich; Stanley R Riddell
Journal:  Sci Signal       Date:  2021-08-24       Impact factor: 8.192

Review 9.  Improving and Maintaining Responses in Pediatric B-Cell Acute Lymphoblastic Leukemia Chimeric Antigen Receptor-T Cell Therapy.

Authors:  Rahul Arya; David M Barrett; Stephan A Grupp; Jan Joseph Melenhorst
Journal:  Cancer J       Date:  2021 Mar-Apr 01       Impact factor: 2.074

Review 10.  How Can We Engineer CAR T Cells to Overcome Resistance?

Authors:  Maya Glover; Stephanie Avraamides; John Maher
Journal:  Biologics       Date:  2021-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.